Blog

  • Observational Data Are Valuable—but Randomized Controlled Trials Remain Essential in Cannabinoid Medicine

    Randomized_Controlled_Trials.jpg

    The clinical use of cannabinoid-based therapies has accelerated dramatically over the past decade, supported by extensive observational research, patient registries, and clinical anecdotes.

  • Join Our Mission: Contract Fundraiser for a Medical Non-Profit

    Contract_Fundraiser.jpg

    Join Our Mission: Contract Fundraiser for a Medical Non-Profit

    Are you passionate about making a difference in healthcare? We are a small but dedicated non-profit medical association committed to educating clinicians and lawmakers about the benefits of cannabinoid medications to improve patient care. Our mission serves patients of all ages, from children to seniors, ensuring they receive the best possible care.

  • Delta-7 THC, Delta-8 THC, Delta-9 THC, Delta-10 THC, and Other Compounds like HHC and THCO-acetate

    Hemp.jpg

    Hemp is seriously complicating the cannabis world.  This is making it harder to treat patients and to safeguard the public health.  There is a range of historical reasons that have led us to this quagmire but regardless of the history and rationale, we have to understand the current situation and how that affects our patients.  

  • Recommendation to Change the Term Adult-Use to Non-medical Use

    ADULT_USE.jpg

    Association of Cannabinoid Specialists (ACS) proposes that the term “adult-use” be changed to “non-medical use” in all communication, laws, and regulation.  The term “adult-use” is inaccurate, stigmatizing, and harmful to the community whereas “non-medical use” is accurate, supportive, and will decrease confusion among consumers.

  • ACS Calls on FDA to do More Than Send Warning Letters to Cannabis Companies Who Violate the Law and Public Trust

    Warning_letter.jpg

    Recently the FDA has sent a warning letter to a California company for marketing an injectable CBD product.  As reported via a variety of outlets, FDA cited multiple legal infractions and gave the company 15 days to comply with all laws and regulations.  Further legal action, of any unspecified nature, was implied in the letter if compliance was not ensured by the due date.  

  • Understanding Cannabis Testing: Ensuring Safety and Quality in an Evolving Industry

    lab_testing.jpg

    The cannabis industry is growing at an unprecedented pace, driven by the legalization wave across the globe. However, as the market expands, so too does the need for robust testing to ensure the safety, quality, and consistency of products. 

  • Supporting Your Endocannabinoid System Beyond Cannabis

    Diet_Sleep_Yoga.jpg

    While cannabis has garnered significant attention for its unique ability to interact with the human Endocannabinoid System, maintaining the health and balance of this vital system can be achieved or supported in ways that are not simply consuming cannabis. A holistic approach that encompasses diet, lifestyle, and therapeutic practices can produce the best results.

  • Clinical Endocannabinoid Deficiency: An Emerging Paradigm in Medicine

    Clinical_Endocannabinoid_Deficiency.jpg

    The concept of Clinical Endocannabinoid Deficiency (CED) is a hypothesis that suggests an underactive endocannabinoid system (ECS) may contribute to the pathogenesis of certain chronic conditions.

  • 5 Tips for Evaluating that New Research Study on Cannabis

    Sources_of_Information.jpg

    You’re scrolling through your news feed and you come across an announcement about a new study that claims cannabis use causes heart disease.

    Should you believe it? Is it trustworthy? How can you tell?

  • Cannabis and Driving: Navigating the Risks and Realities

    driving

    As the legalization of cannabis continues to spread across the United States, a critical concern that has emerged is the increase in driving under the influence of cannabis. This trend poses significant challenges to road safety and public health. Understanding the implications of cannabis-impaired driving is essential for both policymakers, patients, and the general public.